Total Long Term Debt (Quarterly) Chart

View Total Long Term Debt (Quarterly) for HROW.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Long Term Debt (Quarterly) Chart
Start Trial

Historical Total Long Term Debt (Quarterly) Data

View and export this data back to 2007. Start Trial.
Date Value
June 30, 2026 299.80M
March 31, 2026 299.75M
December 31, 2025 251.09M
September 30, 2025 251.01M
June 30, 2025 230.47M
March 31, 2025 229.40M
December 31, 2024 228.33M
September 30, 2024 195.56M
June 30, 2024 191.57M
March 31, 2024 190.86M
December 31, 2023 189.70M
September 30, 2023 188.92M
June 30, 2023 176.65M
March 31, 2023 175.99M
December 31, 2022 111.51M
September 30, 2022 79.76M
June 30, 2022 79.75M
March 31, 2022 78.68M
December 31, 2021 77.68M
September 30, 2021 76.10M
June 30, 2021 75.98M
March 31, 2021 20.18M
December 31, 2020 22.95M
September 30, 2020 23.72M
June 30, 2020 23.60M
Date Value
March 31, 2020 20.39M
December 31, 2019 20.36M
September 30, 2019 19.76M
June 30, 2019 20.12M
March 31, 2019 20.57M
December 31, 2018 15.25M
September 30, 2018 15.28M
June 30, 2018 15.30M
March 31, 2018 15.32M
December 31, 2017 15.33M
September 30, 2017 15.32M
June 30, 2017 13.41M
March 31, 2017 13.87M
December 31, 2016 13.69M
September 30, 2016 11.60M
June 30, 2016 9.421M
March 31, 2016 9.114M
December 31, 2015 8.358M
September 30, 2015 8.245M
June 30, 2015 8.096M
March 31, 2015 0.039M
December 31, 2014 0.0431M
September 30, 2014 0.049M
June 30, 2014 0.0166M
March 31, 2014 0.00

Total Long Term Debt Definition

Represents a company's total debt maturing for more than 12 months of the reporting period.

Read full definition.

Total Long Term Debt (Quarterly) Range, Past 5 Years

View Total Long Term Debt (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Long Term Debt (Quarterly) Benchmarks

View Total Long Term Debt (Quarterly) Benchmarks
Start Trial
Viatris, Inc. 13.51B
Zevra Therapeutics, Inc. 0.87M
Indivior Pharmaceuticals, Inc. 500.00M
Liquidia Corp. 182.90M
60 Degrees Pharmaceuticals, Inc. 0.1512M